Applicant, as named in the Orange Book

Sucampo Pharma Llc

Next listed expiry: Amitiza on 25 Oct 2027. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Amitiza · 2 strengths lubiprostone	lubiprostone	021908	25 Oct 2027	patent